Scientific Sessions attracts nearly 18,000 professional attendees, with a global presence from more than 100 countries. In addition to 2 million medical professionals who participated virtually in lectures and discussions about basic, translational, clinical and population science.
|April 22||Abstract submission opens|
|May 20||Deadline to become an AHA/ASA Professional Member to qualify for priority registration|
|June 1||Late Breaking Clinical Trial submissions open|
|June 3||FAHA/VIP registration and housing opens|
|June 10||Abstract submission closes|
|June 10||Member & Media housing and registration opens|
|June 17||Nonmember registration and housing opens|
|June 22||Late Breaking Clinical Trial submissions close|
|July 1||Exhibitor/Group registration opens|
|July 27||Late Breaking Basic Science submissions open|
|August 19||Late Breaking Basic Science submissions close|
|August 26||Deadline to become an AHA/ASA Professional Member to receive early registration rates|
|September 9||Deadline for early registration rates|
|September 10||Advance registration rates apply|
|September 23||Deadline to become an AHA/ASA Professional Member to receive advance registration rates|
|October 7||Deadline for advance registration rates|
|October 8||Standard registration rates apply|
|November 7 – 8||Resuscitation Science Symposium|
|November 7 – 11||Scientific Sessions 2015|
|November 8 – 10||Exhibits|
|November 10 – 11||Cardiovascular Nursing Clinical Symposium 2015|
Thank you for making Scientific Sessions 2014 an amazing success. You were promised Big Science, Big Networking, Big Technology, and Just Plain Cool interaction in Chicago, and we delivered! We always ask that you expect big things from your AHA scientific events.
An important component of those "big things" will be Frank Sellke, MD, FAHA, who we would like to introduce to you as the new Chair of the Committee of Scientific Sessions Program. He is taking over the reins after the committed and steady stewardship of Robert Harrington, MD.
We are confident that Dr. Sellke will continue the tradition of groundbreaking insights, lectures from prestigious speakers and thought-provoking discussions about basic, translational, clinical and population science at Sessions.
Here's a look back at some of the ground-breaking developments from Chicago:
BIG SCIENCE: Late-Breaking Clinical Trials reveal top-notch research
Topics covered the risks and benefits of dual antiplatelet therapy, anti-lipid therapy and prevention of coronary artery disease, treatment of structural heart disease, and drugs, devices and systems of care for ischemic heart disease. Read more for a recap (link opens in new window).
BIG NETWORKING: Maximizing the Early Career experience
In its second year, we expanded The Early Career Lounge, setting the stage for more networking opportunities.
BIG TECHNOLOGY: Health Tech competition showcases startup medical devices
Building off of the momentum from a successful Health Tech Forum in September, Scientific Sessions introduced a technology track to the conference. See who won the close race (link opens in new window).
JUST PLAIN COOL: Sessions attendees step it up in second annual Walking Challenge
Participating attendees trekked nearly 10.5 million steps while in the Windy City. That's equal to 5,240 miles of walking ... more than the distance of walking from Chicago to Honolulu, Hawaii! We have the individual and council winners (link opens in new window).
The links below have more information on the science presented in 2014 in Chicago.
The American Heart Association’s Scientific Sessions has the best science and is the leading cardiovascular conference for basic, translational, clinical and population science, in the United States.
Scientific Sessions attracts more than 17,000 attendees, with a global presence from more than 100 countries. In addition to 1.5 million medical professionals who participated virtually in lectures and discussions about basic, translational, clinical and population science.
Programming is designed to improve patient care by communicating the most timely and significant advances in basic, clinical, translational and population health research, spanning the full spectrum of cardiovascular disease from a variety of perspectives, from prevention, through diagnosis and through treatment. Sessions includes five days of comprehensive, unparalleled education through more than 5,000 presentations, with 1,000 invited faculty, and 4,000 abstract presentations; all from the world’s leaders in cardiovascular disease. It also includes more than 200 exhibitors showcasing the latest cardiovascular technology and resources.
Lead the way to discovery in the fight against cardiovascular disease and stroke.